Actividad y fenotipos de paraoxonasa-I en una, población de estudiantes universitarios de Lima Perú

Descripción del Articulo

In the present study, it was measured the Paraoxonase-1 (PON1) activity and phenotypes in 89 universities students from Lima-Peru, because previous studies ha ve reported that the PON1 192 Q/R polymorphism could affect the organophosphorus and drug metabolism as well as its protective effect against...

Descripción completa

Detalles Bibliográficos
Autores: Cataño Miraval, Héctor Ciro, Cárdenas Fernández, Anthony Max, Cueva Estela, Jayme Luis, Zavaleta, Amparo I., Izaguirre, Victor, Carranza Alva, Elizabeth
Formato: artículo
Fecha de Publicación:2005
Institución:Universidad Nacional Mayor de San Marcos
Repositorio:Revistas - Universidad Nacional Mayor de San Marcos
Lenguaje:español
OAI Identifier:oai:ojs.csi.unmsm:article/5228
Enlace del recurso:https://revistasinvestigacion.unmsm.edu.pe/index.php/farma/article/view/5228
Nivel de acceso:acceso abierto
Materia:PON1
organaphaspharus
aterosclerosis
pharmacogenetics
192 Q/R polymorphism
organofosforados
farmacagenética
polimorfismo 192 Q/R
Descripción
Sumario:In the present study, it was measured the Paraoxonase-1 (PON1) activity and phenotypes in 89 universities students from Lima-Peru, because previous studies ha ve reported that the PON1 192 Q/R polymorphism could affect the organophosphorus and drug metabolism as well as its protective effect against to development of atherosclerosis. It has found that the mean PON1 activity in the studied population was 167.01 ± 60.84 U/L. The AA, AB Y BB phenotypes from PON1 activity shown frequencies of 0.236, 0.573 and 0.191 respectively. In the studied population PON1 activity has a unimodal distribution and there are more heterozygous individuals AB than homozygous AA or BB. The knowledge of PON1 activity and phenotypes in various populations could be useful for identifying individuals who are more prone to the organophosphorus toxicity or who ha ve a high risk to developed aterosclerosis, and to predict who individuals will not respond to a drug that involve the PON1 participation in íts biotransformation.
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).